Immatics
Andrea Mayer-Mokler is currently the Head and Director Clinical Operations at Immatics Biotechnologies. From April 2002 to August 2005, Andrea served as a Clinical Project Manager/Pharmacovigilance Manager at igeneon-Immunotherapie Forschungs- und Entwicklungs AG. Prior to that, Andrea was a Manager Clinical Research at Merck Sharp & Dohme (MSD) from May 1999 to March 2002. Andrea holds a Dr.scient.med. degree from Medical University of Vienna, a Diplom-Ingenieurin degree in Biotechnology from University of Agricultural Sciences, and a General Master of Business Administration (MBA) degree from Webster University.
This person is not in any offices
Immatics
9 followers
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.